Reconstruction in Extended MArgin Cancer Surgery
Launched by UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST · Jan 20, 2022
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
The clinical trial titled "Reconstruction in Extended Margin Cancer Surgery" is looking at how different methods of surgery and reconstruction can affect patients with advanced pelvic cancers. These cancers are tough to treat and often require removing several organs and tissues, which can lead to complications and impact a patient’s recovery and quality of life. The study aims to gather information on how often these complications occur, the overall health and well-being of patients after surgery, and the costs associated with different reconstruction techniques. By doing this, researchers hope to help doctors and patients make better choices about treatment options.
To participate in this trial, individuals must be 18 years or older and have undergone specific types of surgeries called pelvic exenteration or abdominoperineal excision at the participating hospitals. Participants will be asked to share their experiences, complete health questionnaires, and may take part in interviews to provide deeper insights into their recovery and quality of life. This study is important as it aims to improve the care and outcomes for patients dealing with complex pelvic cancers.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Male and female patients aged 18 or older
- • Patients that have undergone pelvic exenteration or abdominoperineal excision at participating sites, at any time, that have complete data (work package 1 - Colorectal Surgery Database)
- • Patients undergoing pelvic exenteration or abdominoperineal excision at participating sites (work package 2 - prospective study)
- • Patients that have already had pelvic exenteration or abdominoperineal resection that can speak English (work package 3 - mixed-methods study)
- Exclusion Criteria:
- • Patients eligible for, but that are unfit, decline or are not offered abdominoperineal excision or pelvic exenteration surgery
- • Patients that undergo surgery by an intersphincteric abdominoperineal resection approach
- • Patients that are unable to complete the questionnaire over the telephone or online with a researcher
- • Patients unable or unwilling to provide informed consent
- • Patients that are prisoners in the custody of HM Prison Service or who are offenders supervised by the probation service
About University Hospital Southampton Nhs Foundation Trust
University Hospital Southampton NHS Foundation Trust is a leading academic medical center located in the UK, renowned for its commitment to innovative healthcare and research. As a prominent sponsor of clinical trials, the Trust integrates cutting-edge research with clinical practice to advance medical knowledge and improve patient outcomes. With a diverse range of specialties, including cardiology, oncology, and pediatrics, the Trust actively collaborates with academic institutions and industry partners to conduct high-quality trials that adhere to rigorous ethical standards and regulatory guidelines. Its multidisciplinary approach ensures comprehensive patient care while fostering an environment of scientific inquiry and discovery.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Leeds, , United Kingdom
Glasgow, , United Kingdom
Manchester, , United Kingdom
Winchester, , United Kingdom
Southampton, Hampshire, United Kingdom
Basingstoke, , United Kingdom
Salisbury, Wiltshire, United Kingdom
Dorchester, , United Kingdom
Newcastle, , United Kingdom
Poole, , United Kingdom
London, , United Kingdom
Brighton, , United Kingdom
Cornwell, , United Kingdom
Manchester, , United Kingdom
Portsmouth, , United Kingdom
Swansea, , United Kingdom
Wakefield, , United Kingdom
Yeovil, , United Kingdom
Patients applied
Trial Officials
Kashuf Khan, MBBS MRCS
Principal Investigator
University Hospitals Southampton
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials